Remove Clinical Trials Remove Collective Remove Environment Remove Safety
article thumbnail

MAPS: Regulatory Publishing Specialist – Remote Position Regulatory Affairs · Any City, Any State, California

Cannabis Law Report

MAPS PBC strives to continually improve upon the supportive, equitable and accessible work environment. The RPS must enjoy working within a small, entrepreneurial environment in which the ability to work under pressure and to handle a wide variety of activities is necessary. Experience working for a clinical study Sponsor.

article thumbnail

Applied DNA Adds First Summer Camp for safeCircle Pooled COVID-19 Surveillance Testing

Cannabis Law Report

Samples will be collected via anterior nasal swabs that offer ease-of-use for all ages. FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S. Food and Drug Administration (U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CBD is Everywhere – But Where Does the FDA Stand?

The Blunt Truth

CBD is “thriving” in the current regulatory environment, but is it doing so illegally? On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety. The FDA is collecting data to fill these gaps.

CBD 80
article thumbnail

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

They do carry the risk of a “bad trip,” in which anxiety, confusion and unpredictable behavior can be potentially dangerous in the wrong environment. Making sure you have the proper set (the state of your mind) and setting (your environment) is important to minimize these risks.

History 119
article thumbnail

Press Release: Mydecine Secures Financing and Provides Company Update on Clinical Trials, Drug Development and Technology Initiatives

Cannabis Law Report

The Financing will allow the Company to continue progressing its R&D, clinical trials and technology initiatives. “I I’m proud of our accomplishments to date and look forward to kicking off multiple clinical trials in early 2022,” said CEO, Josh Bartch. DENVER, Dec.

article thumbnail

MediPharm Labs Enters into Agreements with Australian Licensed Producer & Forms Multiple Cannabis Supply Partnerships to Advance Australian Market Leadership

Cannabis Law Report

Industrial-scale production will be supported by leading infrastructure designed with ISO standard-built cleanrooms and critical environments that accommodate global Good Manufacturing Practices (“GMP”) workflow. Website: www.medipharmlabs.com.

article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement. Wakshlag, DVM, Ph.D.,

Safety 45